1/25
Vocabulary practice flashcards covering epidemiology, pathology, staging, surgery, lymphatic drainage, tumor markers, and radiation therapy fields and constraints for testicular cancer.

Cryptorchidism
The failure of one or both testes to descend into the scrotum during embryogenesis; represents a major risk factor found in 10% of testicular cancer patients, conferring a 4–5× increased risk compared to the general population.
Pre-pubertal Orchiopexy
A surgical procedure to reposition undescended testes that is thought to have a prophylactic role in preventing testicular cancer in patients with cryptorchidism.

Periaortic Lymph Nodes
The primary landing lymph nodes for testicular cancer due to embryologic site of origin; located along the lumbar vertebrae and below the kidneys (below the renal vein on the left, and along the inferior vena cava on the right).
Thoracic Duct
The lymphatic pathway through which testicular cancer typically spreads in an orderly progression from involved periaortic nodes up to the mediastinal nodes or the left supraclavicular nodes.

Gynecomastia
The development of breast tissue occurring in approximately 5% of testicular cancer patients as a result of tumor hormone secretion.
Alpha-fetoprotein (AFP)
A fetal version of serum albumin that serves as a specific tumor marker for non-seminomas (and hepatocellular carcinoma); it is not elevated in pure seminomas.
Beta-human Chorionic Gonadotropin (β-hCG)
A hormone normally produced by the placenta to maintain pregnancy that can be elevated in both seminomas (15–30% due to syncytiotrophoblastic giant cells) and non-seminomas (choriocarcinoma, embryonal carcinoma).
Lactate Dehydrogenase (LDH)
An enzyme involved in cellular tissue metabolism that serves as a general prognostic marker in testicular cancer, as well as in lymphoma and bone metastases.
Placental Alkaline Phosphatase (PLAP)
A serum laboratory tumor marker utilized specifically for follow-up and monitoring in testicular cancer patients.

High Inguinal Orchiectomy
The primary diagnostic and definitive surgical treatment for testicular cancer, executed via an inguinal incision with high ligation of the spermatic cord.
Trans-scrotal Orchiectomy Approach
A contraindicated surgical approach for suspected testicular tumors that can contaminate scrotal skin lymphatics, creating an indication for adjuvant radiation therapy to the inguinal lymph nodes.
Intratubular Germ-Cell Neoplasia
A precursor carcinoma-in-situ lesion associated with 95% of germ cell tumors, carrying a 50% risk of invasive cancer progression within 5 years.
Spermatocytic Seminoma
A rare germ cell tumor subtype that characteristically affects older men and is an exception to the rule of arising from intratubular germ-cell neoplasia.
Non-Seminoma Germ Cell Tumors (NSGCT)
A major histopathologic category comprising 40% of germ cell tumors; includes embryonal carcinoma, teratoma, choriocarcinoma, yolk sac tumor, and mixed germ cell tumors.
Sex Cord-Stromal Tumors
Non-germ cell testicular neoplasms accounting for 3–4% of testicular tumors, primarily comprising Sertoli cell and Leydig cell tumors.
Pathologic Stage pT1
Tumor limited to the testis and epididymis without vascular or lymphatic invasion; may invade the tunica albuginea.
Pathologic Stage pT2
Tumor limited to the testis and epididymis with vascular or lymphatic invasion, or showing direct invasion of the tunica vaginalis.
Pathologic Stage pT3
Primary testicular tumor staging designation denoting direct extension and invasion into the spermatic cord.
Pathologic Stage pT4
Primary testicular tumor staging designation denoting direct invasion into the scrotum.
Nodal Stages N1, N2, and N3
Regional nodal staging criteria defined by lymph node size: N1 is node(s) ≤2 cm; N2 is node(s) 2 to <5 cm; N3 is node(s) >5 cm.

Periaortic Radiation Field
A radiotherapy field used for early-stage (Stage I) seminoma covering the periaortic, paracaval, interaortocaval, and preaortic nodes; bounded superiorly by the bottom of T-11, inferiorly by the bottom of L-5, and laterally approximately 10 cm wide to encompass the transverse process tips.

Hockey Stick (Dog Leg) Field
An extended radiotherapy field for Stage II seminoma that covers both the periaortic lymphatic chain and the ipsilateral iliac/pelvic lymph node basin.
Seminoma Radiation Therapy Dose
Prescription doses consisting of 20 Gy in 2 Gy fractions for Stage I periaortic fields; 20 Gy in 2 Gy fractions or 25.5 Gy in 1.7 Gy fractions for Stage II hockey stick fields; and 30–36 Gy in 2 Gy fractions for gross nodal mass boosts (GTV+2 cm margin).

Kidney QUANTEC Constraints
Normal tissue tolerance parameters for bilateral kidneys: Mean dose <18 Gy, V28<20%, V23<30%, V20<32%, and V12<55%. If one kidney receives a mean dose >18 Gy, the contralateral kidney is constrained to V6<30%.
Testicular Germinal Epithelium Radiation Tolerance
Extremely radiation-sensitive tissue where scatter radiation doses of 20–50 cGy induce temporary aspermia, and doses of 50 cGy create a risk of permanent aspermia.
Secondary Malignancy Risk
A serious late toxicity of testicular radiotherapy characterized by a 2× general population risk (18.2% incidence at 25 years), particularly affecting the stomach, pancreas, and bladder.